戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 idation included determination of intra- and interassay accuracy and precision values, recovery studi
2 oncentration range of 0.2-200 ng/mL, and the interassay accuracy, intraassay precision, and interassa
3         In conclusion, GA and LA showed good interassay agreement for the detection of most HPV genot
4 mple matrix can affect the commutability and interassay agreement of quantitative BKPyV assays.
5 ble to detect more genotypes per sample, the interassay agreement was acceptable (kappa = 0.53, 63% a
6                                        Here, interassay agreement was evaluated among six real-time n
7                                  The overall interassay agreement, type-specific, and single and mult
8 reference materials is related to intra- and interassay agreement.
9 ential means of increasing commutability and interassay agreement.
10                        There was substantial interassay agreements for the detection of all HPV genot
11 pecificity, but lack of standardization, and interassay and interlaboratory variation makes it diffic
12 roposed clinical thresholds show significant interassay and intrapatient variability.
13 5% coefficient of variation for intra-assay, interassay, and interoperator variability.
14 The cRMP is highly precise with intra-assay, interassay, and total percent CVs of 2.7%, 1.3%, and 2.4
15                                          The interassay coefficient of variability between the experi
16 mpetitive enzyme-linked immunosorbent assay (interassay coefficient of variation < or = 10%) and comp
17  is also simple to use, has a relatively low interassay coefficient of variation (<6%), retains its p
18 uminex assay was precise, with an intra- and interassay coefficient of variation 8.1% and 9.3%; showe
19 ad a <10% interassay relative error and <15% interassay coefficient of variation across a range from
20 y is 200 pmol of MetSO per analysis, and the interassay coefficient of variation is 5.8%.
21 TS13-depleted plasma resulting in an average interassay coefficient of variation of 7.1% and a limit
22                          The intra-assay and interassay coefficient of variation values for the Lyra
23                             CEDIA intra- and interassay coefficients of variation are less than 10%.
24                               The intra- and interassay coefficients of variation values for the Carb
25  approximately 0.1 ng Cd/ml, mean intra- and interassay coefficients of variation were 11-12%.
26                           The intraassay and interassay coefficients of variation were 29 and 40%.
27 nce of these assays and to permit more-valid interassay comparison.
28 ize BKV NAAT results, we anticipate improved interassay comparisons with a potential for establishing
29                                              Interassay concordance and 5-year diabetes prediction of
30                               There was high interassay concordance between measurements of the IGHV
31 ellent agreement between the assays, with an interassay concordance of 91.35% (kappa = 0.75; 95% conf
32 y, intra-assay CV = 7.7% and ICC = 98.2% and interassay CV = 12.3% and ICC = 94.2%).
33 y coefficient of variation (CV) of 4% and an interassay CV of 6% obtained from seven studies, enablin
34 ficient of variation (CV) was 3.1% while the interassay CV was 15%.
35 this assay was between 0.6 and 3.8%, and the interassay CV was between 1.7 and 3.2%.
36 The sensor had excellent precision (1.9-8.2% interassay CV) and was comparable in performance to comm
37 rformance to single-analyte ELISAs (1.9-8.1% interassay CV; <2 ng/mL (or units/mL) detection limit fo
38 and reproducibility (serum assay, intra- and interassay CVs < 3% and ICCs > 99%; urine assay, intra-a
39 fficients of variation [CVs], 0.8%, and mean interassay CVs, 1.6%) and rapid (3.5 min per assay) and
40 %; SP142 CV, 12.17%-109.61%) and significant interassay discordance using QIF (26.6%).
41               While the relationship between interassay harmonization and commutability has been well
42                                              Interassay harmonization of cytomegalovirus (CMV) DNA me
43  Accuracy was >or=85.7% with intra-assay and interassay imprecision<or=13.9 and 12.4%, respectively.
44                                              Interassay mean accuracies were between 101.5 and 104.7%
45                               The intra- and interassay precision (%CV) was within 10.0% and 8.1%, re
46                                              Interassay precision (mean %RSD) ranged from 4.28 to 17.
47                                              Interassay precision (n = 6) was 7%.
48 terassay accuracy, intraassay precision, and interassay precision do not exceed 8.6%, 12%, and 12%, r
49 is more than three orders of magnitude, with interassay precision less than 15%.
50 n of < or =2.5% coefficient of variation and interassay precision of < or =4.0% coefficient of variat
51                             The accuracy and interassay precision of this LC-MS-MS assay for lycopene
52 The coefficients of variation for intra- and interassay precision were less than 9 and 14%, respectiv
53 lidation results were as follows: intra- and interassay precision with %CV of 8.2-9.9 and 7.1-9.8%, r
54  specimen dilution, good clinical intra- and interassay precision, and excellent correlation with the
55 cimens for linearity, intra-assay precision, interassay precision, limit of detection, and specificit
56 were 3.6-10.9 and 4.81-10.21% for intra- and interassay precision, respectively.
57 h acceptable variability for both intra- and interassay precision.
58 alyzed separately, but this fails to capture interassay relationships, making multiassay biomarker di
59                         The assay had a <10% interassay relative error and <15% interassay coefficien
60 s per reaction mixture, (vi) high intra- and interassay reproducibilities, and (vii) correct identifi
61 17.2%, and in buffer down to 5.88 fM with an interassay reproducibility (% RSD, n = 3) of 8.4%.
62 se at concentrations down to 58.8 fM with an interassay reproducibility (%RSD of n = 3) < 17.2%, and
63 orphometric techniques had good to excellent interassay reproducibility (R(2) = 0.62 to 0.96) and int
64             We evaluated the intra-assay and interassay reproducibility at low index levels using thr
65                               Intraassay and interassay reproducibility of PCR and GM was excellent.
66 erent levels of methylation showed excellent interassay reproducibility of RSD (relative standard dev
67                                          The interassay reproducibility was 100% across the four samp
68 ty was found to be between 2.5 and 12.3% and interassay reproducibility was between 6.1 and 15.2% for
69 een the assays (R(2) = 0.99); the intra- and interassay reproducibility was excellent overall (SD = 0
70  variability persists, preventing meaningful interassay result comparison.
71 es are quantitative for all nucleotides, and interassay variabilities are between 5 and 7% when quant
72                                     The mean interassay variabilities were 9.1 and 8.2% for total DPD
73  The estimated standard deviations including interassay variability and intra-assay variability of th
74                               Intraassay and interassay variability averaged 6.7% and 8.9%, respectiv
75 ys are especially subject to high intra- and interassay variability because they are not subject to m
76 btained by chemical synthesis, an intra- and interassay variability below 8% and an accuracy of 92% t
77                    First, we showed that the interassay variability can be greatly reduced when worki
78 cients (ICCs) between antibodies to quantify interassay variability for PD-L1 expression in tumor cel
79                                  Significant interassay variability in the quantification of BK virus
80 ntly improved amplification specificity, and interassay variability is comparable to that of commerci
81 ls heterogeneity within tumors and prominent interassay variability or discordance.
82                                              Interassay variability was low, and the dynamic range wa
83 earity, specificity, sensitivity, intra- and interassay variability, and robustness to sample storage
84 peatability (RSDr = 6% and 9% for intra- and interassay variability, respectively) and specificity: o
85 tform is reproducible with minimal intra- or interassay variability.
86              NucliSens generally showed less interassay variability.
87 f the MAIPA protocol with similar intra- and interassay variance.
88 ultured cells and biological samples with an interassay variation of less than 5%.
89                                   Intra- and interassay variation was less than 10% for a variety of
90 s very accurate and precise, with intra- and interassay variations of less than 3% when 5 microg of p
91 carboxylate (GS4071) to determine intra- and interassay variations.